CBD appears to be a safe drug with no addictive effects, and the preliminary data suggest that it may have therapeutic value for a number of medical conditions. Addressing barriers that slow clinical research with CBD would accelerate progress.
Don't expect there to be a marijuana-related competition scheduled anytime soon, but Tennessee's governor did officially sign legislation into law that will permit a four-year study on the benefits of the medicinally-beneficial cannabinoid Cannabidiol.
According to a soon-to-be-published study conducted at the University of Washington, synthetic cannabinoids are the new drug of choice among military personnel looking for a buzz and attempting to evade regular tox-screenings.
Lawmakers from both the state's House of Representatives and Senate chambers agreed to pass legislation that will allow restricted access to marijuana with high percentages of Cannabidiol (CBD) in order to treat unremitting epileptic seizures and a few other debilitating disorders.
In both instances, the laboratory mice's immune cells created fewer inflammatory molecules, principally one referred to as interleukin 17, or IL-17, which is powerfully related to multiple sclerosis and quite destructive to nerve cells.